Financials
Value Q2, 25Q3, 25Q4, 25Q1, 26Q2, 26 TTM Selling/general/admin expenses 77.01 K201.3 K113.56 K107.69 K145.47 K 568.02 K Research & development ————— — Operating income -77.01 K-274.85 K-203.56 K-197.69 K-235.47 K -911.57 K Non-Operating Income, Total 0905.15 K1.74 M1.58 M1.6 M 5.83 M Interest expense, net of interest capitalized ————— — Non-Operating Income, excl. Interest Expenses 0905.15 K1.74 M1.58 M1.6 M 5.83 M Unusual income/expense ————— — Pretax income -77.01 K630.31 K1.54 M1.39 M1.36 M 4.92 M Equity in earnings ————— — Taxes ————— — Non-controlling/minority interest ————— — After tax other income/expense ————— — Net income before discontinued operations -77.01 K630.31 K1.54 M1.39 M1.36 M 4.92 M Discontinued operations ————— — Net income -77.01 K630.31 K1.54 M1.39 M1.36 M 4.92 M Dilution adjustment ———177.56 M0 — Preferred dividends ———177.56 M1.59 M — Diluted net income available to common stockholders -77.01 K630.31 K1.54 M1.39 M-225.81 K 3.33 M Basic earnings per share (Basic EPS) 0.010.030.090.060.06 0.24 Diluted earnings per share (Diluted EPS) 0.010.030.090.060.06 0.24 Average basic shares outstanding 5 M186.89 K274.91 K450 K450 K — Diluted shares outstanding 5 M186.89 K274.91 K450 K450 K — EBITDA ————— — EBIT ————— — Cost of revenue ————— — Other cost of goods sold ————— — Depreciation & amortization (cash flow) ————— —